High-precision genome surgery in human stem cells

Current Genomics

Volumn 7, Issue 7, 2006, Pages 427-433

  Zhou, Ruijie ^a   Dröge, Peter ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Gene targeting; Genome engineering; Genome stability; Human stem cells; Insertional mutagenesis

Indexed keywords

CRE RECOMBINASE; RECOMBINASE;

DNA RECOMBINATION; DNA STRAND BREAKAGE; DNA VECTOR; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE INSERTION; GENE TARGETING; GENETIC SELECTION; GENETIC STABILITY; GENETIC TRANSFECTION; GENOMICS; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN GENOME; NONHUMAN; PROKARYOTIC CELL; REVIEW; SITE DIRECTED MUTAGENESIS; TRANSGENE; VIRUS VECTOR;

EID: 33845625094     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920206779116774     Document Type: Review

References (35)

1. James, D., Noggle, S.A., Swigut, T. and Brivanlou, A.H. Contribution of human embryonic stem cells to mouse blastocysts. Dev. Biol. 2006, 295: 90-102.
2. McNeish, J. Embryonic stem cells in drug discovery. Nat. Rev. Drug Disc. 2004, 3: 70-80.
3. Hook, L., O'Brien, C. and Allsopp, T. ES cell technology: An introduction to genetic manipulation, differentiation and therapeutic cloning. Adv. Drug Del. Rev. 2005, 57:1904-1917.
4. Hows, J. Adult stem cell therapy beyond haemopoietic stem cell transplantation? An update. Transpl. Immunol. 2005, 14: 221-223.
5. Mendez, P., Wang, L. and Bhatia, M. Genetic manipulation of human embryonic stem cells: A system to study early human development and potential therapeutic applications. Curr. Gene Ther. 2005, 5: 1-11.
6. Glover, D.J., Lipps, H.J. and Jans, D.A. Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. Genet. 2005, 4, 299-310.
7. Thomas, C.E., Ehrhardt, A. and Kay, M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 2003, 4: 346-358.
8. Grindley, N.D.F., Whiteson, K.L., Rice, P.A. Mechanisms of site-specific recombination. Annu. Rev. Biochem. 2006, 75: 567-605.
9. Tan, S.M. and Dröge, P. Comparative analysis of sequence-specific DNA recombgination systems in human embryonic stem cells. Stem Cells 2005, 23: 868-873.
10. Branda, C.S. and Dymecki, S.M. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev. Cell 2004, 1: 7-28.
11. Nolden, L., Edenhofer, F., Haupt, S., Koch, P., Wunderlich, F.T., Siemen, H. And Brüstle, O. Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase. Nat. Methods 2006, 3: 461-467.
12. Araki, K., Araki, M. and Yarnamura, K. Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res. 1997, 25: 868-872.
13. Toledo, F., Liu, C.W., Lee, C.J. and Wahl, G.M. RMCE-ASAP: a gene targeting method for ES and somatic cells to accelerate phenotype analyses. Nucleic Acids Res. 2006, 34:e92.
14. Missirlis, P.I., Smailus, D.E. and Holt, R.A. A high-throughput screen identifying sequence and promiscuity characteristics of the loxP spacer region in Cre-mediated recombination. BMC Genomics 2006, 7: 73.
15. Belteki, G., Gertsenstein, M., Ow, D.W. and Nagy, A. Site-specific cassette exchange and germline transmission with mouse ES cells expressing φC31 integrase. Nat. Biotech. 2003, 21: 321-324.
16. Smith, M.C. and Till, R. Switching the polarity of a bacteriophage integration system. Mol. Microbiol. 2004, 51: 1719-1728.
17. Groth, A.C. and Calos, M.P. Phage integrases: biology and applications. J. Mol. Biol. 2004, 335: 667-678.
18. Thyagarajan, B., Lakshmipathy, U. and Chestnut, J. Creation of an engineered human embryonal carcinoma cell line with site-specific integration. 4th ISSCR Annual Meeting, Toronto, Ontario, Canada, 2006, pp. 47.
19. Chalberg, T.W., Portlock, J.L., Olivares, E.C., Thyagarajan, B., Kirby, P.J., Hillman, R.T., Hoelters, J. and Calos, M.P. Integration specificity ofphage phiC31 integrase in the human genome. J. Mol. Biol. 2006, 357: 28-48.
20. Dave, U.P., Jenkins, N.A. and Copeland, N.G. Gene therapy insertional mutagenesis insights. Science 2004, 303: 333.
21. Ginsburg, D.S. and Calos, M.P. Site-specific integration with φC31 integrase for prolonged expression of therapeutic genes. Adv. Genetics 2005, 54: 179-187.
22. Quenneville, S.P., Chapdelaine, P., Rousseau, J., Beaulieu, J., Caron, N.J., Skuk, D., Mills, P., Olivares, E.C., Calos, M.P. and Tremblay, J.P. Nucleofection of muscle-derived stem cells and myoblasts with φC31 integrasc: stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol. Therapy 2004, 10: 679-687.
23. Andreas, S., Schwenk, F., Kuter-Luks, B., Faust, N. and Kuhn, R. Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: Activity comparison with Cre and FLPe recombinase in mammalian cells. Nucleic Acids Res. 2002, 30: 2299-2306.
24. Thyagarajan, B., Guimaraes, M.J., Groth, A.C. and Calos, M.P. Mammalian genomes contain active recombinase recognition sites. Gene 2000, 244: 47-54.
25. Schmidt, E.E., Taylor, D.S., Prigge, J.R., Barnett, S. and Capecchi, M. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermadis. Proc. Natl. Acad. Sci. USA 2000, 97: 13702-13707.
26. Loonstra, A., Vooijs, M., Beverloo, H.B., Allak, B.A., van Drunen, E., Kanaar, R. and Berns, A. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc. Natl. Acad. Sci. USA 2001, 98: 9209-9214.
27. Liu, J., Nielsen, K. and Jensen, T.G. φC31 integrase induces chromosomal aberrations in primary human fibroblasts. Gene Therapy 2006, 13: 1188-1190.
28. Capecchi, M.R. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat. Rev. Genet. 2005, 6: 507-512.
29. Grimm, D. Mouse genetics. A mouse for every gene. Science, 312: 1862-1866.
30. Zwaka, T.P. and Thomson, J.A. Homologous recombination in human embryonic stem cells. Nat. Biotech. 2003, 21: 319-321.
31. Urbach, A., Schuldiner, M. and Benvenisty, N. Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells 2004, 22: 635-641.
32. Durai, S., Mani, M., Kandavelou, K., Wu, J., Porteus, M.H. and Chandrasegaran, S. Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells. Nucleic Acids Res. 2005, 33: 5978-5990.
33. Urnov, F.D., Miller, J.C., Lee, Y.L., Beausejour, C.M., Rock, J.M., Augustus, S., Jamieson, A.C., Porteus, M.H., Gregory, P.D. and Holmes, M.C. Highly efficient endogenous human gene conversion using zinc-finger nucleases. Nature 2005, 435: 646-651.
34. Chamberlain, J.R., Schwarze, U., Wang, P-R, Hirata, R.K., Hankenson, K.D., Pace, J.M., Underwood, R.A., Song, K.M., Sussman, M., Byers, P.H. and Russell, D.W. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 2004, 303: 1198-1201.
35. Bushman, F.D. Integration site selection by lentiviruses: biology and possible control. Curr. Top. Microb. Immunol. 2002, 261: 165-77.